Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study

Taylor and Francis Group, Expert Opinion on Drug Safety, 12(22), p. 1283-1287, 2023

Journal article published in 2023 by Romain Barus

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by